Rose Bengal Acetate PhotoDynamic Therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cells

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Panzarini, Elisa ^a   Inguscio, Valentina ^a   Fimia, Gian Maria ^a,b   Dini, Luciana ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CALRETICULIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; ROSE BENGAL; ROSE BENGAL ACETATE; UNCLASSIFIED DRUG; FLUORESCENT DYE; HEAT SHOCK PROTEIN; HMGB1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL ASSAY; CELL DEATH; CELL MEMBRANE; CELL SURFACE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IMMUNOGENIC CELL DEATH; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; DRUG EFFECTS; GENETICS; LIGHT; MACROPHAGE; METABOLISM; PHOTOCHEMOTHERAPY; RADIATION RESPONSE;

APOPTOSIS; AUTOPHAGY; CALRETICULIN; FLUORESCENT DYES; HEAT-SHOCK PROTEINS; HELA CELLS; HMGB1 PROTEIN; HUMANS; LIGHT; MACROPHAGES; PHOTOCHEMOTHERAPY; ROSE BENGAL;

EID: 84936856118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105778     Document Type: Article

References (47)

1. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
2. Green DR, Ferguson T, Zitvogel L, Kroemer G (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363.
3. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, et al. (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12: 860-875.
4. Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy Annu Rev Immunol 31: 51-72.
5. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, et al. (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1805: 53-71.
6. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, et al. (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54-61. (Pubitemid 46067386)
7. Galluzzi L, Kepp O, Kroemer G (2012) Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 31: 1055-1057.
8. Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, et al. (2011) Human tumor cells killed by anthracyclines induce a tumor-specific immune response. Cancer Res 71: 4821-4833.
9. Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, et al. (2007) Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109: 4839-4845. (Pubitemid 46827780)
10. Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 61: 215-221.
11. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, et al. (2012) A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 31: 1062-1079.
12. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, et al. (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15: 1170-1178.
13. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, et al. (2008) Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15: 3-12. (Pubitemid 350286167)
14. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, et al. (2001) Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 167: 2602-2607. (Pubitemid 32768888)
15. Kono H, Chen CJ, Ontiveros F, Rock KL (2010) Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 120: 1939-1949.
16. Foell D, Wittkowski H, Vogl T, Roth J (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81: 28-37. (Pubitemid 46021248)
17. Luheshi NM, Giles JA, Lopez-Castejon G, Brough D (2012) Sphingosine regulates the NLRP3-inflammasome and IL-1b release from macrophages. Eur J Immunol 42: 716-725.
18. Srikrishna G, Freeze HH (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11: 615-628.
19. Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P (2013) Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev 24: 319-333.
20. Korbelik M, Zhang W, Merchant S (2011) Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunol Immunother 60: 1431-1437.
21. Zhou F, Xing D, Chen WR (2009) Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells. Int J Cancer 125: 1380-1389.
22. Panzarini E, Inguscio V, Dini L (2013) Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? Biomed Res Int 2013: 482160.
23. Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T (2009) Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 24: 259-268.
24. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, et al. (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61: 250-281.
25. Korbelik M, Sun J, Cecic I (2005) Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 65: 1018-1026. (Pubitemid 40216464)
26. Zhou F, Xing D, Chen WR (2008) Dynamics and mechanism of HSP70 translocation induced by photodynamic therapy treatment. Cancer Lett 264: 135-144.
27. Mitra S, Giesselman BR, De Jesús-Andino FJ, Foster TH (2011) Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70. Lasers Surg Med 43: 632-643.
28. Etminan N, Peters C, Lakbir D, Bünemann E, Börger V, et al. (2011) Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. Br J Cancer 105: 961-969.
29. Panzarini E, Tenuzzo B, Palazzo F, Chionna A, Dini L (2006) Apoptosis induction and mitochondria alteration in human HeLa tumor cells by photoproducts of Rose Bengal acetate. J Photochem Photobiol B 83: 39-47. (Pubitemid 43372641)
30. Panzarini E, Tenuzzo B, Dini L (2009) Photodynamic therapy-induced apoptosis of HeLa cells. Ann NY Acad Sci 1171: 617-626.
31. Panzarini E, Inguscio V, Dini L (2011) Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy. Cell Death Dis Jun 9; 2: e169.
32. Panzarini E, Inguscio V, Dini L (2011) Overview of cell death mechanisms induced by Rose Bengal Acetate-photodynamic therapy. Int J Photoenergy 2011; ID 713726.
33. Dini L, Inguscio V, Tenuzzo B, Panzarini E (2010) Rose Bengal Acetate PhotodynamicTherapy-induced autophagy. Cancer Biol Ther 10: 1048-1055.
34. Panzarini E, Inguscio V, Tenuzzo BA, Dini L (2013) In vitro and in vivo clearance of Rose Bengal Acetate-PhotoDynamic Therapy-induced autophagic and apoptotic cells. Exp Biol Med 238: 765-778.
35. Johnson S, Michalak M, Opas M, Eggleton P (2001) The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol 11(3): 122-129. doi:org/10.1016/S0962-8924(01)01926-2.
36. Davies AM, Lara PN Jr, Mack PC, Gandara DR (2007) Incorporating bortezomib into the treatment of lung cancer. Clin Cancer Res 13: s4647-4651.
37. Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, et al. (2007) Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 109: 4839-4845. (Pubitemid 46827780)
38. D'Eliseo D, Manzi L, Velotti F (2013) Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells. Cell Stress Chaperones 18: 801-808.
39. Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, et al. (2011). Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev 30: 61-69.
40. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, et al. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321-334. (Pubitemid 41457220)
41. Gardai SJ, Bratton DL, Ogden CA, Henson PM (2006) Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79: 896-903. (Pubitemid 44835574)
42. Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, et al. (2008) The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ. 15: 1499-1509.
43. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol. 81: 15-27. (Pubitemid 46021247)
44. Green DR, Ferguson T, Zitvogel L, Kroemer G (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9: 353-363.
45. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195. (Pubitemid 34773774)
46. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, et al. (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 16: 175-183.
47. Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, et al. (2012) Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 1: 179-188.